(6/8) If you don’t treat the ulcers, you have severe pain and complications, if you do treat them you are dealing w… https://t.co/70nlNrcXFw
Archives
(8/8) You might not see something physically wrong
(8/8) You might not see something physically wrong, but these kids are working their butt off through some horrific… https://t.co/Qea40rtm0y
I get my initial biologic therapy infusion for #cr
I get my initial biologic therapy infusion for #crohnsdisease next week!!!! 🥳
What have we learned so far from the COVID-19 pand
What have we learned so far from the COVID-19 pandemic and how can we use it to improve biosimilars development and… https://t.co/hY3S77Yakw
https://t.co/7PS79cyV6S for Biosimilars Latam–Co
https://t.co/7PS79cyV6S for Biosimilars Latam–Colombia 2021 Online Forum on June 23rd,24th & 25th 2021… https://t.co/qGaQvJBsdC
Better Uptake Found for Recently Launched vs Older
Better Uptake Found for Recently Launched vs Older #Biosimilars: https://t.co/r43HJVdsUV https://t.co/7ZyctiNTRy
@LadyD420Empath #CrohnsDisease #RA
What’s the impact of government intervention on
What’s the impact of government intervention on competition in the growing marketplace with biosimilars? Amgen’s Ch… https://t.co/wkN02DWRQH
A new study examines “how quickly biosimilars/foll
A new study examines “how quickly biosimilars/follow-on products gained market share and the subsequent trajectory… https://t.co/dlsEGsG8Xq
A new study examines “how quickly biosimilars/foll
A new study examines “how quickly biosimilars/follow-on products gained market share and the subsequent trajectory… https://t.co/DgvPLjUBpR